COMPARISON OF HIGH-FAT AND HIGH-CARBOHYDRATE DIETS FOR OBTAINING AN EXPERIMENTAL MODEL OF METABOLIC SYNDROME

T. S. Petryn, M. R. Nagalievska, N. O. Sybirna


DOI: http://dx.doi.org/10.30970/sbi.1501.642

Abstract


Introduction. Metabolic syndrome is a cluster of metabolic abnormalities that includes hypertension, central obesity, insulin resistance and atherogenic dyslipidemia. Given the wide geographical distribution and growing number of people suffering from this disease, there is an urgent need in developing animal models that would accurately reproduce the development of all symptoms of human metabolic syndrome (insulin resistance, dyslipidemia, obesity and hypertension). The most cost-effective method related to the real causes of metabolic syndrome is the use of different types of diets.
Materials and Methods. The study was performed on white outbred male rats about 6 months old and weighing 300–400 g. The metabolic syndrome was induced by high-fat and high-carbohydrate diets. The lipid-enriched diet involved the consumption of regular chow diet for laboratory animals with additional fat content (40 % by weight of chow). The source of additional lipids was olive oil, which is rich in monounsaturated fatty acids (MUFAs). Animals on the diet enriched in carbohydrates together with regular chow diet for laboratory animals consumed 10 % fructose solution instead of drinking water. Glucose tolerance tests were conducted and areas under the glycemic curves were calculated. We determined the content of glycated hemoglobin and glucose concent­ration, the concentration of low-density lipoproteins (LDL), high-density lipoproteins (HDL), triglycerides and cholesterol in the blood plasma of rats.
Results. The development of metabolic syndrome induced by an excessive consumption of carbohydrates and lipids for 42 days was accompanied by impaired glucose tolerance, increased glycosylated hemoglobin, triglycerides and cholesterol concentrations, as well as a decreased HDL content. An increase in the concentrations of LDL and activity of paraoxonase were found due to the induction of the pathological condition by an excessive fat intake, while a high carbohydrate diet caused a decrease in paraoxonase activity.
Conclusions. The use of fructose for 42 days causes the most pronounced manifestations of the studied pathology. The use of this model will allow determining the biochemical and molecular changes that accompany the development of this pathological condition. It will also facilitate the development and evaluation of the effectiveness of new therapeutic approaches to the treatment of metabolic syndrome.


Keywords


metabolic syndrome, diet-induced obesity models, hyperglycemia, dyslipidemia

Full Text:

PDF

References


1. Alaminos-Castillo M.Á., Ho-Plagaro A., García-Serrano S. et al. Increased PON lactonase activity in morbidly obese patients is associated with impaired lipid profile. International Journal of Clinical Practice, 2019; 73(6): e13315.
CrossrefPubMedGoogle Scholar

2. Aydin S., Aksoy A., Aydin S., Kalayci M., Yilmaz M., Kuloglu T., Citil C., Catak Z. Today's and yesterday's of pathophysiology: Biochemistry of metabolic syndrome and animal models. Nutrition, 2014; 30(1): 1-9.
CrossrefPubMedGoogle Scholar

3. Buettner R. Parhofer K.G., Woenckhaus M., Wrede C.E., Kunz-Schughart L.A., Schölme­rich J., Bollheimer L.C. Defining high-fat-diet rat models: metabolic and molecular effects of different fat types. Journal of Molecular Endocrinology, 2006; 36(3): 485-501.
CrossrefPubMedGoogle Scholar

4. Burtis C. A., Ashwood E. R., Bruns D. E. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. 5rd ed. St. Louis, USA: Elsevier Health Sciences, 2012. 2238 p.
Google Scholar

5. Cameron A.J., Shaw J.E., Zimmet P.Z. The metabolic syndrome: prevalence in worldwide populations. Endocrinology and Metabolism Clinics of North America, 2004; 33: 351-375.
CrossrefPubMedGoogle Scholar

6. Carr M., Brunzell J. Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk. The Journal of Clinical Endocrinology & Metabolism, 2004; 89(6): 2601-2607.
CrossrefPubMedGoogle Scholar

7. Dantoine T.F., Debord J., Charmes J.P., Merle L., Marquet P., Lachatre G., Leroux-Robert C. Decrease of serum paraoxonase activity in chronic renal failure. Journal of the American Society of Nephrology, 1998; 9(11): 2082-2088.
PubMedGoogle Scholar

8. Del Moral M.L., Esteban F.J., Torres M.I. et al. High-fat sunflower and olive oil diets affect serum lipid levels in steatotic rat liver differently. J Nutr Sci Vitaminol (Tokyo), 1997; 43(1): 155-160.
CrossrefPubMedGoogle Scholar

9. Ivanova E.A., Myasoedova V.A., Melnichenko A.A., Grechko A.V., Orekhov A.N. Small dense low-density lipoprotein as biomarker for atherosclerotic diseases. Oxidative Medicine and Cellular Longevity, 2017; 2017: 1273042.
CrossrefPubMedPMCGoogle Scholar

10. James W., Rigby N., Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil, 2004; 11(1): 3-8.
CrossrefPubMedGoogle Scholar

11. Kolovou G.D., Anagnostopoulou K.K., Cokkinos D.V. Pathophysiology of dyslipidaemia in the metabolic syndrome. Postgraduate Medical Journal, 2005; 81(956): 358-366.
CrossrefPubMedPMCGoogle Scholar

12. Kotur-Stevuljević J., Vekić J., Stefanović A. et al. Paraoxonase 1 and atherosclerosis-related diseases. BioFactors, 2020; 46(2): 193-205.
CrossrefPubMedGoogle Scholar

13. Ong K.T., Mashek M.T., Bu S.Y., Greenberg A.S., Mashek D.G. Adipose triglyceride lipase is a major hepatic lipase that regulates triacylglycerol turnover and fatty acid signaling and partitioning. Hepatology, 2011; 53(1): 116-126.
CrossrefPubMedPMCGoogle Scholar

14. Rifai N., Bachorik P.S., Albers J.J. Lipids, lipoprotein and apolipoprotein. In: Burtis C.A., Ashwood E.R. (Ed.). Tietz textbook of clinical chemistry. 3rd ed. Philadelphia: WB Saunders Company, 1999: 806-861.
Google Scholar

15. Rochlani Y., Pothineni N.V., Kovelamudi S., Mehta J.L. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis, 2017; 11(8): 215-225.
CrossrefPubMedPMCGoogle Scholar

16. Sánchez-Lozada L.G., Tapia E., Jiménez A. et al. Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular dama­ge in rats. Am J Physiol Renal Physiol, 2007; 292(1): F423-F429.
CrossrefPubMedGoogle Scholar

17. Saudek C.D., Derr R.L., Kalyani R.R., Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c. JAMA, 2006; 295: 1688-1697.
CrossrefPubMedGoogle Scholar

18. Sweazea K.L., Lekic M., Walker B.R. Comparison of mechanisms involved in impaired vascular reactivity between high sucrose and high fat diets in rats. Nutrition & Metabolism, 2010; 7(1): 48.
CrossrefPubMedPMCGoogle Scholar

19. Wong S.K., Chin K.Y., Suhaimi F.H., Fairus A., Ima-Nirwana S. Animal models of metabolic syndrome: a review. Nutrition & Metabolism, 2016; 13(1): 65-76.
CrossrefPubMedPMCGoogle Scholar

20. Yeh S.T. Using trapezoidal rule for the area under a curve calculation. Proceedings of the Twenty-Seventh Annual SAS. User Group International (SUGI) Conference, 2002; 27: 229-237.

21. Young D.S. Effects of drugs on clinical laboratory tests. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1997; 34(6): 579-581.
CrossrefPubMedGoogle Scholar


Refbacks

  • There are currently no refbacks.


Copyright (c) 2021 T. S. Petryn, M. R. Nagalievska, N. O. Sybirna

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.